Finally, ongoing telehealth follow-up supports dose titration and side-effect management
Pharm Res (2019) 2(1):513
(2023) Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA
Using tritylamine as an ammonia equivalent has been previously described by Castellino and co-workers 54
I keep an eye on this space because, despite considerable issues with nausea, vomiting, muscle loss, and even rare cases of sudden blindness, the GLP-1 RA drugs may offer the first real hope for patients with metabolic syndrome associated with chronic ulcers
Exposure of the liver to xenobiotic substances means the body prepares itself by increasing detoxification enzymes, i.e., cytochrome P-450 mixed-function oxidase